Precision BioSciences
DTIL
86 hedge funds and large institutions have $36.5M invested in Precision BioSciences in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 27 increasing their positions, 27 reducing their positions, and 21 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 27
2.68% less ownership
Funds ownership: 46.15% → 43.47% (-2.7%)
11% less call options, than puts
Call options by funds: $8K | Put options by funds: $9K
14% less funds holding
Funds holding: 100 → 86 (-14)
40% less capital invested
Capital invested by funds: $60.9M → $36.5M (-$24.5M)
67% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 21
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$4.72M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$952K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$864K |
| 4 |
JP Morgan Chase
New York
|
+$569K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$402K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$5.99M |
| 2 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$3.16M |
| 3 |
Millennium Management
New York
|
-$1.19M |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$355K |
| 5 |
CCMU
Cheyne Capital Management (UK)
London,
United Kingdom
|
-$226K |
DTIL Hedge Fund Activity: Q1 2023 in Review
86 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q1 2023, worth a combined $36.5M — down 40% from $60.9M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of DTIL and 7 opened new positions — a net loss of 14 holders — while 27 trimmed existing stakes and 27 added.
The largest buyer was Great Point Partners, adding an estimated $4.72M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $5.99M sold.
- 86 institutional investors held Precision BioSciences (DTIL) as of Q1 2023, down from 100 in Q4 2022.
- Funds reported $36.5M of Precision BioSciences stock for Q1 2023, down 40% quarter-over-quarter.
- 7 funds opened new Precision BioSciences positions in Q1 2023 and 21 closed out, a net change of -14 holders.
- The largest Precision BioSciences buyer in Q1 2023 was Great Point Partners, an estimated $4.72M added.
- The largest Precision BioSciences seller in Q1 2023 was EcoR1 Capital, an estimated $5.99M sold.
Based on aggregated 13F filings for Q1 2023.